Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers

Abstract Data about the duration of humoral response following COVID-19 vaccines are mandatory to establish appropriate population vaccination strategy. This study reports on the antibody decline observed in a population of COVID-19 naïve and COVID-19 positive individuals having received the two dose regimen of the BNT162b2 vaccine. Six months after vaccination, a significant antibody decline was observed in both COVID-19 naïve and positive individuals. The estimated half-life of total and IgG antibodies differs and ranges from several months for total antibodies to only several weeks for IgG antibodies, explaining the significant proportions of participants with non-detectable levels of neutralizing antibodies at 6 months. Whether this decrease correlates with an equivalent drop in the clinical effectiveness against the virus will require appropriate clinical studies. Nevertheless, these data are already important to support the decision-making on the potential use of a booster dose..

Medienart:

Preprint

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

ResearchSquare.com - (2021) vom: 03. Sept. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

Bayart, Jean-Louis [VerfasserIn]
Douxfils, Jonathan [VerfasserIn]
Gillot, Constant [VerfasserIn]
David, Clara [VerfasserIn]
Mullier, François [VerfasserIn]
Elsen, Marc [VerfasserIn]
Eucher, Christine [VerfasserIn]
Eeckhoudt, Sandrine Van [VerfasserIn]
Roy, Tatiana [VerfasserIn]
Gerin, Vincent [VerfasserIn]
Wieers, Grégoire [VerfasserIn]
Laurent, Christine [VerfasserIn]
Closset, Mélanie [VerfasserIn]
Dogné, Jean-Michel [VerfasserIn]
Favresse, Julien [VerfasserIn]

Links:

Volltext [kostenfrei]

doi:

10.21203/rs.3.rs-862966/v1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XRA033444773